expenses (17,485) (10,233) (46,236) (27,964) General and administrative expenses (9,215) (2,769) (25,488) (7,147) Other income 32 190 232 315 ---------- -------------------- ---------- --------------- Operating result (18,797) (7,756) (49,685) (20,731) Financial income 1,188 2,844 1,943 3,339 Financial expenses (6,717) (61) (6,499) (158) Share listing expense (152,787) - (152,787) - Financial result (158,316) 2,783 (157,343) (3,181) ---------- -------------------- ---------- --------------- Loss before taxes (177,113) (4,973) (207,028) (17,550) Taxes on income - - - - - ---------- -------------------- ---------- --------------- Net loss (177,113) (4,973) (207,028) (17,550) Attributable to: Equity holders of the parent (177,113) (4,711) (206,471) (16,859) Non-controlling interest - (262) (557) (691) Net loss (177,113) (4,973) (207,028) (17,550) Net loss per share--basic and diluted (2.82) (0.14) (4.80) (0.51) ) ---------- -------------------- ---------- --------------- Weighted average shares outstanding--basic and diluted 62,908,617 33,093,838 43,032,098 33,093,838 ---------- -------------------- ---------- --------------- Immatics N.V. and subsidiaries Unaudited Condensed Consolidated Statement of Comprehensive Loss of Immatics N.V. Three months ended September Nine months ended September 30, 30, ------------------------------ ----------------------------- 2020 2019 2020 2019 ------------ ---------------- ----------------- ---------- (Euros in thousands) (Euros in thousands) ------------------------------ ----------------------------- Net Loss (177,113) (4,973) (207,028) (17,550) ------------ ---------------- ----------------- ---------- Other comprehensive loss Items that may be reclassified subsequently to profit or loss, net of tax - - - - Currency translation differences from foreign operations (3,487) (727) (3,387) (735) ------------ ---------------- ----------------- ---------- Total comprehensive loss for the period (180,600) (5,700) (210,415) (18,285) Attributable to: Equity holders of the parent (180,600) (5,438) (209,858) (17,594) Non-controlling interest - (262) (557) (691) --------------------------------- ------------ ---------------- ----------------- ---------- Total comprehensive loss for the period (180,600) (5,700) (210,415) (18,285) ------------ ---------------- ----------------- ---------- Immatics N.V. and subsidiaries Unaudited Condensed Consolidated Statement of Cash Flows of Immatics N.V. Nine months ended September 30, ----------------------------- 2020 2019 ------------- -------------- (Euros in thousands) ----------------------------- Cash flows from operating activities Loss before taxation (207,028) (17,550) ------------- -------------- Adjustments for: Interest income (1,072) (439) Depreciation and amortization 3,466 2,795 Interest expense 188 138 Share listing expense 152,787 - Equity settled share-based payment 15,031 116 MD Anderson compensation expense 45 503 (Decrease) Increase in other liabilities resulting from share appreciation rights (1,893) 151 Payment related to share-based compensation awards previously classified as equity-settled (4,322) - Changes in working capital Decrease (increase) in accounts receivable 328 (720) (Increase) decrease in other assets (2,211) 432 (Increase) decrease in accounts payable and other current liabilities (16,026) 56,739 Interest received 1,030 341 Interest paid (188) (138) Net cash provided by/(used in) operating activities (59,865) 42,368 ------------- -------------- Cash flows from investing activities Payments for property, plant and equipment (5,864) (1,403) Cash paid for investments classified in Other financial assets (58,482) (4,450) Cash received from maturity of investments classified in Other financial assets 48,881 17,551 Payments for intangible assets (86) (60) Proceeds from disposal of property, plant and equipment - 97 Net cash provided by/(used in) investing activities (15,551) 11,735 ------------- -------------- Cash flows from financing activities Proceeds from issuance of shares to equity holders of the parent 209,369 - Payments for leases (1,633) (1,395) Net cash provided by/(used in) financing activities 207,736 (1,395) ------------- -------------- Net increase in cash and cash equivalents 132,320 52,708 ============= ============== Cash and cash equivalents at beginning of period 103,353 39,367 ============= ============== Effects of exchange rate changes on cash and cash equivalents (1,997) 16 Cash and cash equivalents at end of period 233,676 92,091 ------------- -------------- Immatics N.V. and subsidiaries Unaudited Condensed Consolidated Statement of Changes in Shareholders' equity (deficit) of Immatics N.V. Total equity attributable Total to shareholders share-holders' Share Share Accumulated Other of the Non-controlling equity (Euros in thousands) capital premium deficit reserves parent interest (deficit) ------------------------------ -------- -------- -------------- --------- ---------------- --------------- --------------- Balance as of January 1, 2019 1,164 190,793 (201,623) (741) (10,407) 1,236 (9,171) -------- -------- -------------- --------- ---------------- --------------- --------------- Other comprehensive loss - - - (735) (735) - (735)
(MORE TO FOLLOW) Dow Jones Newswires
December 02, 2020 07:00 ET (12:00 GMT)